483
Hisamitsu Pharmaceutical Co., Inc.Hisamitsu Pharmaceutical Co., Inc. – FDA 483, May 31, 2019
Record Details
Hisamitsu Pharmaceutical Co., Inc., a drug manufacturer in Tosu, Japan, was cited for significant deficiencies in quality control and laboratory procedures. Observations included failing to reject out-of-specification drug products, inadequate impurity testing, and a lack of written procedures for invalidating aborted tests. The firm also failed to review raw electronic analytical data prior to batch release for products distributed in the U.S.
View Company Profile
ID · 7538a4f6-92de-411e-8105-38c145bacc97
Other documents for Hisamitsu Pharmaceutical Co., Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.